Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · IEX Real-Time Price · USD
1.850
-0.270 (-12.74%)
At close: Apr 19, 2024, 4:00 PM
1.900
+0.050 (2.70%)
After-hours: Apr 19, 2024, 6:34 PM EDT
Tevogen Bio Holdings Market Cap
Tevogen Bio Holdings has a market cap or net worth of $304.54 million as of April 19, 2024. Its market cap has decreased by -39.90% in one year.
Market Cap
304.54M
Enterprise Value
403.67M
1-Year Change
-39.90%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since November 4, 2021, Tevogen Bio Holdings's market cap has decreased from $421.50M to $304.54M, a decrease of -27.75%. That is a compound annual growth rate of -12.40%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 324.90M | -7.22% |
Apr 17, 2024 | 350.20M | -3.18% |
Apr 16, 2024 | 361.70M | 0.44% |
Apr 15, 2024 | 360.10M | -4.10% |
Apr 12, 2024 | 375.50M | -0.79% |
Apr 11, 2024 | 378.50M | 0.80% |
Apr 10, 2024 | 375.50M | 4.28% |
Apr 9, 2024 | 360.10M | -12.98% |
Apr 8, 2024 | 413.80M | -7.53% |
Apr 5, 2024 | 447.50M | -14.11% |
Apr 4, 2024 | 521.00M | 29.76% |
Apr 3, 2024 | 401.50M | -11.19% |
Apr 2, 2024 | 452.10M | -8.56% |
Apr 1, 2024 | 494.40M | -13.97% |
Mar 28, 2024 | 574.70M | 8.07% |
Mar 27, 2024 | 531.80M | -10.65% |
Mar 26, 2024 | 595.20M | -2.17% |
Mar 25, 2024 | 608.40M | -9.38% |
Mar 22, 2024 | 671.40M | 2.60% |
Mar 21, 2024 | 654.40M | -3.82% |
Mar 20, 2024 | 680.40M | -2.21% |
Mar 19, 2024 | 695.80M | -6.39% |
Mar 18, 2024 | 743.30M | -21.39% |
Mar 15, 2024 | 945.50M | -5.08% |
Mar 14, 2024 | 996.10M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
iTeos Therapeutics | 382.80M |
Sonida Senior Living | 378.30M |
Surmodics | 377.54M |
Solid Biosciences | 377.19M |
Cibus | 376.70M |
Anika Therapeutics | 376.12M |
Pacific Biosciences of California | 375.13M |
Amarin Corporation | 374.93M |